The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Alunbrig is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
The global Alunbrig market was valued at US$ 182.9 million in 2023 and is anticipated to reach US$ 349.7 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alunbrig, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alunbrig.
Report Scope
The Alunbrig market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alunbrig market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alunbrig manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Segment by Type
30mg
50mg
180mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alunbrig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alunbrig in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Alunbrig is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.
The global Alunbrig market was valued at US$ 182.9 million in 2023 and is anticipated to reach US$ 349.7 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Alunbrig, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alunbrig.
Report Scope
The Alunbrig market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alunbrig market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alunbrig manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Segment by Type
30mg
50mg
180mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alunbrig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alunbrig in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Alunbrig Market Overview
1.1 Product Overview and Scope of Alunbrig
1.2 Alunbrig Segment by Type
1.2.1 Global Alunbrig Market Value Comparison by Type (2024-2030)
1.2.2 30mg
1.2.3 50mg
1.2.4 180mg
1.3 Alunbrig Segment by Application
1.3.1 Global Alunbrig Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Alunbrig Market Size Estimates and Forecasts
1.4.1 Global Alunbrig Revenue 2019-2030
1.4.2 Global Alunbrig Sales 2019-2030
1.4.3 Global Alunbrig Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alunbrig Market Competition by Manufacturers
2.1 Global Alunbrig Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alunbrig Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alunbrig Average Price by Manufacturers (2019-2024)
2.4 Global Alunbrig Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alunbrig, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alunbrig, Product Type & Application
2.7 Alunbrig Market Competitive Situation and Trends
2.7.1 Alunbrig Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alunbrig Players Market Share by Revenue
2.7.3 Global Alunbrig Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alunbrig Retrospective Market Scenario by Region
3.1 Global Alunbrig Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alunbrig Global Alunbrig Sales by Region: 2019-2030
3.2.1 Global Alunbrig Sales by Region: 2019-2024
3.2.2 Global Alunbrig Sales by Region: 2025-2030
3.3 Global Alunbrig Global Alunbrig Revenue by Region: 2019-2030
3.3.1 Global Alunbrig Revenue by Region: 2019-2024
3.3.2 Global Alunbrig Revenue by Region: 2025-2030
3.4 North America Alunbrig Market Facts & Figures by Country
3.4.1 North America Alunbrig Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alunbrig Sales by Country (2019-2030)
3.4.3 North America Alunbrig Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alunbrig Market Facts & Figures by Country
3.5.1 Europe Alunbrig Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alunbrig Sales by Country (2019-2030)
3.5.3 Europe Alunbrig Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alunbrig Market Facts & Figures by Country
3.6.1 Asia Pacific Alunbrig Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alunbrig Sales by Country (2019-2030)
3.6.3 Asia Pacific Alunbrig Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alunbrig Market Facts & Figures by Country
3.7.1 Latin America Alunbrig Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alunbrig Sales by Country (2019-2030)
3.7.3 Latin America Alunbrig Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alunbrig Market Facts & Figures by Country
3.8.1 Middle East and Africa Alunbrig Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alunbrig Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alunbrig Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Alunbrig Sales by Type (2019-2030)
4.1.1 Global Alunbrig Sales by Type (2019-2024)
4.1.2 Global Alunbrig Sales by Type (2025-2030)
4.1.3 Global Alunbrig Sales Market Share by Type (2019-2030)
4.2 Global Alunbrig Revenue by Type (2019-2030)
4.2.1 Global Alunbrig Revenue by Type (2019-2024)
4.2.2 Global Alunbrig Revenue by Type (2025-2030)
4.2.3 Global Alunbrig Revenue Market Share by Type (2019-2030)
4.3 Global Alunbrig Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alunbrig Sales by Application (2019-2030)
5.1.1 Global Alunbrig Sales by Application (2019-2024)
5.1.2 Global Alunbrig Sales by Application (2025-2030)
5.1.3 Global Alunbrig Sales Market Share by Application (2019-2030)
5.2 Global Alunbrig Revenue by Application (2019-2030)
5.2.1 Global Alunbrig Revenue by Application (2019-2024)
5.2.2 Global Alunbrig Revenue by Application (2025-2030)
5.2.3 Global Alunbrig Revenue Market Share by Application (2019-2030)
5.3 Global Alunbrig Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Alunbrig Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Alunbrig Product Portfolio
6.1.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alunbrig Industry Chain Analysis
7.2 Alunbrig Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alunbrig Production Mode & Process
7.4 Alunbrig Sales and Marketing
7.4.1 Alunbrig Sales Channels
7.4.2 Alunbrig Distributors
7.5 Alunbrig Customers
8 Alunbrig Market Dynamics
8.1 Alunbrig Industry Trends
8.2 Alunbrig Market Drivers
8.3 Alunbrig Market Challenges
8.4 Alunbrig Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
